Supplementation as a new opportunity of management of the climacteric
Оразов М. Р., Токтар Л. Р., Radzinskiy V. E., Хамошина М. Б., Soyunov M. A., Орехов Р. Е.
Вопросы гинекологии, акушерства и перинатологии
Т. 19, Вып. 1, С. 123-131
Опубликовано: 2020
Тип ресурса: Статья
DOI:10.20953/1726-1678-2020-1-123-131
Аннотация:
Objective. To study the possibility of using supplementation in management of patients suffering from climacteric disorders and having a risk of asthenia and depressive disorders. Patients and methods. The study included 70 menopausal female patients who presented with complaints about specific vasomotor symptoms of the climacteric in combination with complaints about emotional lability, sleep disorders, apathy, decreased memory performance and concentration problems, sexual disorders. All patients received transdermal oestradiol 0.06[%] in combination with continuous monophasic micronized progesterone therapy. 35 patients additionally to menopausal hormonal therapy (MHT) received supplementation with a Famvital complex for 12 wks according to instructions. Results. A statistically significant improvement of all parameters on the Greene scale and the Spielberger–Hanin scale (anxiety assessment) was obtained in patients who additionally to MHT received supplement therapy as compared to th
Ключевые слова:
Menopausal hormonal therapy; Menopause; Supplementation
estradiol; famvital complex; nutrition supplement; progesterone; unclassified drug; apathy; Article; asthenia; comparative study; concentration loss; depression; female; female sexual dysfunction; hormonal therapy; human; major clinical study; memory disorder; menopausal syndrome; mental instability; patient care; risk assessment; sleep disorder; treatment outcome; vasomotor disorder; vitamin supplementation
Язык текста: Русский
ISSN: 2414-9152
Оразов М. Р.
Токтар Л. Р.
Radzinskiy V. E.
Хамошина М. Б.
Soyunov M. A.
Орехов Р. Е.
Orazov M. R.
Toktar L. R.
Радзинскиy В. Е.
Khamoshina M. B.
Союнов М. А.
Orekhov R. E.
Supplementation as a new opportunity of management of the climacteric
Текст визуальный непосредственный
Вопросы гинекологии, акушерства и перинатологии
ООО "Издательство "Династия"
Т. 19, Вып. 1 С. 123-131
2020
Статья
Menopausal hormonal therapy Menopause Supplementation
estradiol famvital complex nutrition supplement progesterone unclassified drug apathy Article asthenia comparative study concentration loss depression female female sexual dysfunction hormonal therapy human major clinical study memory disorder menopausal syndrome mental instability patient care risk assessment sleep disorder treatment outcome vasomotor disorder vitamin supplementation
Objective. To study the possibility of using supplementation in management of patients suffering from climacteric disorders and having a risk of asthenia and depressive disorders. Patients and methods. The study included 70 menopausal female patients who presented with complaints about specific vasomotor symptoms of the climacteric in combination with complaints about emotional lability, sleep disorders, apathy, decreased memory performance and concentration problems, sexual disorders. All patients received transdermal oestradiol 0.06[%] in combination with continuous monophasic micronized progesterone therapy. 35 patients additionally to menopausal hormonal therapy (MHT) received supplementation with a Famvital complex for 12 wks according to instructions. Results. A statistically significant improvement of all parameters on the Greene scale and the Spielberger–Hanin scale (anxiety assessment) was obtained in patients who additionally to MHT received supplement therapy as compared to th